Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Saccharomyces cerevisiae peptides are derived from the yeast species S. cerevisiae, widely known for its use in baking and brewing. In recent years, yeast-derived peptides, including those from S. cerevisiae, have been investigated for their bioactive properties, such as antioxidant, immunomodulatory, and anti-inflammatory effects. Scientific studies, primarily in vitro and in animal models, have demonstrated that S. cerevisiae peptides can enhance immune responses, promote tissue repair, and combat oxidative stress. These properties are potentially beneficial during convalescence, a period marked by the need for immune system support and tissue recovery following illness or surgery. Some clinical trials suggest that yeast peptide supplements may improve nutritional status, immune function, and overall recovery in certain populations, such as the elderly or those recovering from infections. However, while there is a growing body of scientific literature on the general health benefits of yeast peptides, robust, large-scale clinical trials specifically targeting convalescence in humans remain limited. The evidence is stronger than mere traditional use (which is minimal for this specific application), but it does not reach the highest standard of clinical validation. As a result, the scientific justification for using S. cerevisiae peptides during convalescence is promising but still emerging, meriting a moderate rating.

More about Saccharomyces cerevisiae peptides
More about Convalescence

Other ingredients used for Convalescence

Other health conditions supported by Saccharomyces cerevisiae peptides

Products containing Saccharomyces cerevisiae peptides